LATS1 and cancer: Likewise, in the Hippo pathway, a negative regulator of proliferation in normal cells, loss-of-function mutations in NF2 and LATS1/2 genes and gene amplification of YAP gene as a gain-of-function mutation in cancers have been reported16.